Cannabix Technologies Stock Forecast, Price & News

+0.02 (+1.84 %)
(As of 05/5/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume90,651 shs
Average Volume521,519 shs
Market Capitalization$116.25 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive BLOZF News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabix Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Phone604 551 7831
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Market Cap$116.25 million
Next Earnings DateN/A
OptionableNot Optionable


See More Headlines
Cannabix Technologies logo

About Cannabix Technologies

Cannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the workplace in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.


Overall MarketRank

0.64 out of 5 stars

Business Services Sector

298th out of 441 stocks

Medical Devices Industry

10th out of 35 stocks

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Cannabix Technologies (OTCMKTS:BLOZF) Frequently Asked Questions

What stocks does MarketBeat like better than Cannabix Technologies?

Wall Street analysts have given Cannabix Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cannabix Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Cannabix Technologies' stock price been impacted by COVID-19?

Cannabix Technologies' stock was trading at $0.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BLOZF stock has increased by 191.0% and is now trading at $1.1058.
View which stocks have been most impacted by COVID-19

Who are Cannabix Technologies' key executives?

Cannabix Technologies' management team includes the following people:
  • Mr. Ravinder S. Mlait B.A., M.B.A., BA, MBA, CEO & Director (Age 45, Pay $113.3k)
  • Mr. Kulwant Sing Malhi, Pres & Director (Age 54, Pay $134.05k)
  • Mr. Bryan E. Loree CPA, C.M.A., B.A., CMA, CFO, Corp. Sec. & Director (Age 45, Pay $98.94k)
  • Dr. Rajpaul Attariwala, Chief Scientific Officer & Independent Director (Age 53, Pay $98.94k)
  • Dr. Marilyn Huestis, Consultant & Scientific Advisor

Who are some of Cannabix Technologies' key competitors?

What is Cannabix Technologies' stock symbol?

Cannabix Technologies trades on the OTCMKTS under the ticker symbol "BLOZF."

How do I buy shares of Cannabix Technologies?

Shares of BLOZF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cannabix Technologies' stock price today?

One share of BLOZF stock can currently be purchased for approximately $1.11.

How much money does Cannabix Technologies make?

Cannabix Technologies has a market capitalization of $116.25 million.

What is Cannabix Technologies' official website?

The official website for Cannabix Technologies is www.cannabixtechnologies.com.

How can I contact Cannabix Technologies?

The company can be reached via phone at 604 551 7831.

This page was last updated on 5/5/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.